Australia should turn its experience reducing smoking rates to the obesity epidemic by introducing more obvious labels on unhealthy foods, making workplaces run staff health checks and speeding up the development of crucial medications, the head of a leading drug company says.
Mike Doustdar, president of Novo Nordisk, which created the weight-loss wonder drug Ozempic, said the 13 million Australians who were overweight or obese were making the nation less productive and putting extra strain on the health system.
